Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
4DMedical Ltd ( (AU:4DX) ) has issued an announcement.
4DMedical Ltd has announced the quotation of 2,872,980 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective September 25, 2025. This move is part of the company’s strategic efforts to enhance its market presence and provide additional value to its stakeholders by expanding its financial resources.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates in the medical technology industry, focusing on developing advanced imaging solutions. The company is known for its innovative lung imaging platform, which aims to enhance diagnostic capabilities and improve patient outcomes.
Average Trading Volume: 6,041,673
Technical Sentiment Signal: Buy
Current Market Cap: A$752.1M
See more data about 4DX stock on TipRanks’ Stock Analysis page.